We further found that the probability of detecting MGMT promoter methylation among all patient GBM samples showed a daily rhythm that peaked around noon (Fig. 1D, average trace scored circadian by JTK cycle, p < 0.05), varying by at least 20% over the course of the day. Here, MGMT is linked to glioblastoma.